Layoff rumors in Danaher Life Sciences - what's the real story?

I've been hearing a lot of chatter lately about potential layoffs within Danaher's Life Sciences segment. It seems to be concentrated in certain areas, maybe related to specific acquisitions or underperforming business units. I haven't seen any official numbers or communications, but the whispers are getting louder. Is anyone here from LSI who has direct knowledge or has experienced something recently? I'm trying to separate fact from fiction. Are these just standard operational adjustments, or is something bigger brewing? Any insights from management or HR that people are willing to share (anonymously, of course) would be greatly appreciated. It's tough to plan or even focus when you're in the dark like this. Feels like we're waiting for the other shoe to drop.